Issue 14, 2021

Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections

Abstract

Lower respiratory tract infections (LRTIs) are one of the leading causes of deaths in the world. Currently available treatment for this disease is with high doses of antibiotics which need to be administered frequently. Instead, pulmonary delivery of drugs has been considered as one of the most efficient routes of drug delivery to the targeted areas as it provides rapid onset of action, direct deposition of drugs into the lungs, and better therapeutic effects at low doses and is self-administrable by the patients. Thus, there is a need for scientists to design more convenient pulmonary drug delivery systems towards the innovation of a novel treatment system for LRTIs. Drug-encapsulating polymer nanoparticles have been investigated for lung delivery which could significantly reduce the limitations of the currently available treatment system for LRTIs. However, the selection of an appropriate polymer carrier for the drugs is a critical issue for the successful formulations of inhalable nanoparticles. In this review, the current understanding of LRTIs, management systems for this disease and their limitations, pulmonary drug delivery systems and the challenges of drug delivery through the pulmonary route are discussed. Drug-encapsulating polymer nanoparticles for lung delivery, antibiotics used in pulmonary delivery and drug encapsulation techniques have also been reviewed. A strong emphasis is placed on the impact of drug delivery into the infected lungs.

Graphical abstract: Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections

Article information

Article type
Review Article
Submitted
19 mar 2021
Accepted
16 may 2021
First published
17 may 2021
This article is Open Access
Creative Commons BY license

Nanoscale Adv., 2021,3, 4005-4018

Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections

M. Z. Rahman Sabuj and N. Islam, Nanoscale Adv., 2021, 3, 4005 DOI: 10.1039/D1NA00205H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements